AI-based Measurements of Tumour Burden in PSMA PET-CT
NCT: NCT06363435 · RECRUITING
Brief Summary
The primary aim of the present study is to evaluate how automatically calculated (by an AI-based method) tumour burden, measured as tumour volume (TV) and as tumour uptake (TU: TV x SUVmean) in the prostate/prostate bed, pelvic lymph nodes, distant lymph nodes, bone and as the total tumour burden predicts overall survival (OS) in patients with prostate cancer (newly diagnosed and patients with biochemical recurrence).
Frequently Asked Questions
What is AI-based Measurements of Tumour Burden in PSMA PET-CT?
AI-based Measurements of Tumour Burden in PSMA PET-CT is a clinical trial registered under NCT06363435. Current status: RECRUITING.
What is the status of NCT06363435?
The current status of NCT06363435 (AI-based Measurements of Tumour Burden in PSMA PET-CT) is: RECRUITING.
When did AI-based Measurements of Tumour Burden in PSMA PET-CT start?
AI-based Measurements of Tumour Burden in PSMA PET-CT started on 2024-03-29.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.